EGFR antibodies in resectable metastatic colorectal liver metastasis: more harm than benefit?
Lancet Oncol
.
2020 Mar;21(3):324-326.
doi: 10.1016/S1470-2045(20)30003-6.
Epub 2020 Jan 31.
Authors
Sepideh Gholami
1
,
Axel Grothey
2
Affiliations
1
Department of Surgery, University of California, Davis, Sacramento, CA 95817, USA. Electronic address: sgholami@ucdavis.edu.
2
West Cancer Center and Research Institute, Germantown, TN, USA.
PMID:
32014120
DOI:
10.1016/S1470-2045(20)30003-6
No abstract available
Publication types
Comment
MeSH terms
Cetuximab
Colorectal Neoplasms*
ErbB Receptors
Humans
Liver Neoplasms*
Substances
EGFR protein, human
ErbB Receptors
Cetuximab